Olmesartan EP Impurity A

Olmesartan EP Impurity A is a synthetic byproduct generated during the formation of the tetrazole ring in olmesartan synthesis. It retains the benzene core with a 1,5-disubstituted tetrazole ring but lacks the hydroxymethyl group at the C-5 position, replaced instead by a methylene bridge connecting to an additional amino functionality. The compound maintains the propionyl imide and methyl substituents characteristic of the parent drug. Structural differences arise from an incomplete cyclization step, introducing an exocyclic amine. This impurity serves as an HPLC reference standard for quantifying this specific degradation pathway in olmesartan formulations.